Norovirus GI

A positive stool result can help explain a sudden bout of vomiting and diarrhea. It becomes less clear-cut when you've recently recovered or have no symptoms, because viral genetic material can remain in stool after the illness ends.

The distinction matters if your report includes a number. Detecting the virus's genetic material in stool is an established way to support a diagnosis. Using the quantity to predict how sick you'll get, when you'll recover, or when you can no longer infect someone else is much less certain.

What the Test Detects

Norovirus GI refers to genogroup I within the norovirus family. Genogroups separate viruses according to genetic similarities. Genogroups I and II cause most human infections, with genogroup II accounting for the larger share. This result covers genogroup I, so a negative result leaves genogroup II unassessed.

The virus carries its genetic instructions as RNA and infects cells in the intestine. Inherited differences in sugar molecules on the gut lining affect susceptibility to some strains, which helps explain why people exposed to the same outbreak don't all become ill.

This stool test uses qPCR. For an RNA virus, the laboratory first converts RNA into DNA, then makes repeated copies of a selected viral sequence while measuring the signal. This process is called RT-qPCR. It detects genetic material from both infectious and noninfectious virus, so a positive result alone cannot establish contagiousness.

How Your Number Is Reported

The catalog lists CFU/g stool as the reporting unit. CFU means colony-forming units and normally describes organisms that grow into colonies. Norovirus doesn't form bacterial colonies, and PCR doesn't count colonies. The supplied test information doesn't explain how this unit is assigned to the viral RNA result, so its numerical meaning needs clarification from the laboratory.

Published quantitative studies generally report viral RNA copies or genome copies per gram of stool. Those quantities cannot be converted into this report's CFU/g stool without documented validation linking the two scales. Results from different assays also depend on sample processing and reference materials. The studies below support stool RNA detection and describe research findings; they do not validate this catalog's numerical scale as a measure of severity or recovery.

Acute Gastroenteritis

Acute gastroenteritis is a sudden illness involving vomiting and diarrhea. A 2014 analysis of studies worldwide detected norovirus in about 18% of acute gastroenteritis cases. That estimate includes different genogroups and should not be read as the share caused by genogroup I.

Symptoms usually begin 12 to 48 hours after exposure, and most people recover within 1 to 3 days. Dehydration is the main immediate danger, especially in young children, older adults, and people with weakened immunity.

What Stool Viral Load Can Tell You

Some studies link greater amounts of stool RNA to worse illness. In a cancer-center study, higher loads were associated with more severe gastroenteritis, and genogroup II infections had higher loads than genogroup I infections. The researchers used a separate quantitative RNA assay, with results expressed as copies per gram.

That pattern doesn't hold consistently across studies. A pediatric study found no relationship between the starting norovirus load and illness severity. In experimental infections, volunteers given one genogroup I strain shed about a hundred times more RNA than volunteers given one genogroup II strain, even though the genogroup II strain caused more symptoms. These findings do not support a rule that genogroup I always produces lower loads or milder disease.

A stool quantity has to be read alongside symptoms, the stage of infection, and immune health. It cannot reliably grade dehydration or determine how urgently you need care.

Chronic Infection When Immunity Is Weak

People with inborn immune disorders or weakened immunity during cancer treatment or after transplantation can develop prolonged norovirus infection. Diarrhea and poor nutrient absorption may persist, and stool RNA can remain detectable for months or years. Long-term surveillance has documented chronic infections involving both genogroups I and II. Persistent diarrhea still has other possible causes, including medicines and other infections.

Older Adults With Other Health Problems

A US Veterans Health Administration study examined results from more than 23,000 people who were tested for norovirus. Positive results were associated with a small increase in hospitalization and a higher risk of death during the first three days after testing compared with negative results. The study covered norovirus in general and largely involved older adults with other illnesses. It does not establish that a particular genogroup I quantity predicts those outcomes.

Detection Without Symptoms

In a Japanese study of about 4,500 adults without gastroenteritis symptoms, 2.5% had norovirus RNA in stool. Both genogroups I and II were represented. A positive result can therefore occur without an illness that needs treatment, although symptom-free detection does not establish that the virus cannot spread.

How It Compares With Other Norovirus Tests

RT-qPCR is the preferred laboratory method for detecting norovirus. Rapid antigen tests look for viral proteins and can miss infections, especially genogroup I. Published evaluations illustrate the difference, but each result below belongs to the named assay and study population; none establishes the accuracy of this catalog's unspecified qPCR kit.

PCR can also miss infections. Genetic differences between strains can prevent an assay from recognizing its target, and low amounts of RNA or substances that interfere with the reaction can reduce detection.

How Results Change Over Time

RNA shedding often lasts much longer than vomiting or diarrhea. Experimental infections with a genogroup I strain and a genogroup II strain produced shedding that continued for weeks after symptoms ended. In a separate pediatric study, 70% of children who supplied a follow-up sample were still positive 28 days after enrollment. Almost all infections in that pediatric study were genogroup II, so its duration estimate is not specific to genogroup I.

A falling RNA measurement can accompany recovery, but sampling and assay variation also affect the number. Persistent detection in someone with ongoing diarrhea and weakened immunity may support chronic infection. Neither a falling quantity nor a single negative sample establishes that all transmission risk has ended.

When Results Can Be Misleading

• Recent infection or no symptoms: RNA can remain detectable after recovery, and infection can occur without symptoms. A positive result may not explain a new episode of diarrhea.
• Another cause of illness: other pathogens, medicines, and noninfectious conditions can cause diarrhea even when norovirus RNA is present.
• Genogroup coverage: this result addresses genogroup I. A negative result does not rule out genogroup II or other stomach viruses.
• Strain differences: some genogroup I strains have been missed by particular PCR assays when their sequences did not match the assay's targets.
• Collection and processing: substances in stool can inhibit PCR. Improper storage, unsuitable preservatives, low RNA amounts, and differences in extraction can also affect detection or quantity.
• Unclear reporting units: a number labeled CFU/g stool needs a laboratory explanation of how the value is derived before it can be interpreted as a viral quantity.

False positives are also possible. Two evaluations of syndromic multiplex gastrointestinal PCR panels, including the BIOFIRE FILMARRAY, found that a substantial share of positive norovirus calls were not confirmed by follow-up testing. These findings concern the platforms and samples studied, including combined genogroup I/II results. They should not be treated as the false-positive rate of all stool PCR tests or of this assay.